Biosense Webster, Inc.
Clinical trials sponsored by Biosense Webster, Inc., explained in plain language.
A medical device company specializing in cardiac electrophysiology and catheter-based treatments.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New heart mapping catheter put to the test Results expected Sep 2026 (estimated)
- New heart tool aims to simplify AFib treatment Results expected Dec 2026 (estimated)
- New heart tool aims to make AFib treatment faster and safer Results expected Dec 2026 (estimated)
- New catheter combo aims to keep AFib in check longer Results expected Dec 2026 (estimated)
- New heart procedure aims to zap away atrial fibrillation safely Results expected Jul 2027 (estimated)
-
New heart catheter shows promise for AFib patients
Disease control CompletedThis study tested a new device called the OMNYPULSE catheter with the TRUPULSE generator to treat paroxysmal atrial fibrillation (a type of irregular heartbeat). The goal was to see if it is safe and effective at isolating the veins that carry blood from the lungs to the heart. 1…
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New heart catheter shows promise for AFib patients
Disease control CompletedThis study tested a special catheter system to treat people with a type of irregular heartbeat called paroxysmal atrial fibrillation (PAF) that didn't get better with medication. The treatment uses heat energy to isolate the veins that trigger the abnormal rhythm. The study inclu…
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
New heart procedure could free AF patients from daily pills
Disease control CompletedThis study tested a new device that uses electrical pulses to treat a type of irregular heartbeat called paroxysmal atrial fibrillation. 142 people who had not been helped by standard medications took part. The goal was to see if the procedure could keep their heart rhythm normal…
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New heart catheter shows promise for stopping AFib episodes
Disease control CompletedThis study tested a special catheter and generator system to treat people with paroxysmal atrial fibrillation (AFib), a condition where the heart beats irregularly. The goal was to safely isolate the veins that trigger AFib and restore normal rhythm. 135 participants were treated…
Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Balloon catheter aims to zap away irregular heartbeat
Disease control CompletedThis phase 3 trial tested a special balloon catheter that uses radiofrequency energy to destroy tiny areas of heart tissue causing irregular heartbeats in people with symptomatic paroxysmal atrial fibrillation. The study enrolled 397 adults who had not responded to medication. Th…
Phase 3 • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
New heart mapping algorithm aims to tame chaotic rhythms
Symptom relief CompletedThis study tested a computer algorithm called CartoFinder to help doctors better identify and treat complex heart rhythm problems (arrhythmias). 70 adults with persistent atrial fibrillation (a type of irregular heartbeat) took part. The goal was to see if the algorithm could imp…
Sponsor: Biosense Webster, Inc. • Aim: Symptom relief
Last updated Jun 27, 2026 14:00 UTC